Alzheimer's drug shows promise in early results of stud...

Shares of Biogen and other drugmakers researching Alzheimer’s disease soared early Wednesday after Japan’s Eisai Co. said its potential treatment appeared to slow the fatal disease in a late-stage study

Related Keywords

Cambridge ,Cambridgeshire ,United Kingdom ,Eli Lilly ,Graig Suvannavejh ,Japan Eisai Co ,Alzheimer Association ,Drug Administration ,Eisai Co ,Biogen Inc ,Mizuho Securities ,Massachusetts Based Biogen ,Indianapolis Based Eli Lilly ,